首页 | 本学科首页   官方微博 | 高级检索  
     

人体激肽释放酶2与前列腺癌
引用本文:杨丹,董守良. 人体激肽释放酶2与前列腺癌[J]. 生命的化学, 2008, 28(6)
作者姓名:杨丹  董守良
作者单位:兰州大学生命科学学院生物化学与分子生物学研究所,兰州,730000;兰州大学生命科学学院生物化学与分子生物学研究所,兰州,730000
摘    要:人体激肽释放酶2(human kallikrein 2,hK2)是一种主要在前列腺中表达的丝氨酸蛋白酶,近年作为前列腺癌的血清标记物受到广泛关注.随着对hK2结构特征、组织表达、生物学活性和调节,及其与前列腺癌病理过程的关系的研究更一步深入,hK2在前列腺癌诊断、病理分期及治疗中的潜在应用价值将越加瞩目.

关 键 词:人体激肽释放酶2  前列腺癌

Human kallikrein 2 and prostate cancer
Dan YANG,Shou-Liang DONG. Human kallikrein 2 and prostate cancer[J]. Chemistry of Life, 2008, 28(6)
Authors:Dan YANG  Shou-Liang DONG
Affiliation:Dan YANG Shou-Liang DONG (Institute of Biochemistry , Molecular Biology,School of Life Sciences,Lanzhou University,Lanzhou 730000,China)
Abstract:Human glandular kallikrein 2 (hK2) is a serine protease mainly expressed in the prostate gland. Since it is a potential biomarker of prostate cancer, great attentions have been focused on hK2 in recent years. While recent researches have made accumulated knowledge on hK2, such as its structure, tissue expression, activities and its regulation, especially the association of hK2 with prostate cancer progression, it will be more remarkable that hK2 could be a clinical candidate in prostate cancer detection, pa...
Keywords:human glandular kallikrein 2  activities  regulation  prostate cancer  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号